Cristiano Noto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Cristiano Noto has a total of 258 co-authors. Here are the top co-authors by number of shared publications:
- Ary Gadelha
Department of Psychiatry, Universidade Federal de São Paulo, Brazil
36 shared publications - Rodrigo Affonsecca Bressan
Federal University of São Paulo, São Paulo, Brazil
27 shared publications - Sintia Iole Belangero
Universidade Federal de São Paulo (UNIFESP)
21 shared publications - Elisa Brietzke
Department of Psychiatry, Queen’s University School of Medicine, Kingston, ON K7L 3N6, Canada
16 shared publications - Michael Maes
Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
14 shared publications Quirino Cordeiro
Grupo de Atenção às Psicose Iniciais (GAPi), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Centro de Pesquisa e Inovação em Prevenção de Transtornos Mentais e Uso de Álcool e Outras Drogas (CEPIPREV), Health Ministry, Brazil
14 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- p. 1-23
Early psychosis care in Brazil: a comparative study of a specialized university center and community-based services
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)
- 1 January 2026
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- p. 1-23
Open AccessEarly psychosis care in Brazil: a comparative study of a specialized university center and community-based services
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)
- Open Access
- 17 October 2025
- Published by Wiley
Peer-Mediated Cognitive Enrichment in First-Episode Psychosis: A Pilot Feasibility Study Using the Feuerstein Approach
Background : Translating cognitive remediation gains into everyday functioning remains limited in schizophrenia. We evaluated a peer-mediated Feuerstein Instrumental Enrichment (FIE) approach, grounded in mediated learning principles, in individuals in the early phase of illness. The FIE approach utilizes small-group sessions, mediator oversight, and explicitly guided transfer strategies to promote metacognitive reflection and strengthen real-world generalization. Objective : This pilot study aimed to assess the feasibility and acceptability of a peer-mediated FIE program in first-episode psychosis (FEP) and to generate preliminary signals of its effect on patient-centered functional outcomes. Methods : In this open-label, single-arm pilot study, 16 individuals with FEP participated in a 10-week, group-based FIE program. Outcomes were assessed at baseline (T0), post-intervention (T1), and 6-month follow-up (T2). The primary outcome was patient-centered functioning, measured by the Goal Attainment Scale (GAS). Secondary outcomes included cognitive domains (MCCB) and symptom severity (PANSS). Change over time were analyzed using the non-parametric Friedman test. Results : The intervention demonstrated excellent feasibility, with 100% participant retention. Significant and sustained improvements were observed in patient-defined functional goals (GAS; χ2(2)=24.43, p<.001). Additionally, preliminary cognitive gains emerged in Processing Speed, as measured by the Coding subtest (χ2(2)=10.47, p<.005), and in Verbal Working Memory, assessed by the Letter–Number Span (χ2(2)=10.34, p<.006), suggesting domain-specific enhancement of cognitive efficiency and working memory manipulation. Furthermore, significant reductions were noted in positive, general, and total PANSS scores, while negative symptoms remained stable. Conclusions : Peer-mediated FIE is a highly feasible and acceptable intervention for individuals with FEP. The promising preliminary signals on patient-centered functioning and specific cognitive domains strongly support the need for a large-scale randomized controlled trial with an active control group to definitively establish efficacy.
- 17 October 2025
- Published by Wiley
Open AccessPeer-Mediated Cognitive Enrichment in First-Episode Psychosis: A Pilot Feasibility Study Using the Feuerstein Approach
Background : Translating cognitive remediation gains into everyday functioning remains limited in schizophrenia. We evaluated a peer-mediated Feuerstein Instrumental Enrichment (FIE) approach, grounded in mediated learning principles, in individuals in the early phase of illness. The FIE approach utilizes small-group sessions, mediator oversight, and explicitly guided transfer strategies to promote metacognitive reflection and strengthen real-world generalization. Objective : This pilot study aimed to assess the feasibility and acceptability of a peer-mediated FIE program in first-episode psychosis (FEP) and to generate preliminary signals of its effect on patient-centered functional outcomes. Methods : In this open-label, single-arm pilot study, 16 individuals with FEP participated in a 10-week, group-based FIE program. Outcomes were assessed at baseline (T0), post-intervention (T1), and 6-month follow-up (T2). The primary outcome was patient-centered functioning, measured by the Goal Attainment Scale (GAS). Secondary outcomes included cognitive domains (MCCB) and symptom severity (PANSS). Change over time were analyzed using the non-parametric Friedman test. Results : The intervention demonstrated excellent feasibility, with 100% participant retention. Significant and sustained improvements were observed in patient-defined functional goals (GAS; χ2(2)=24.43, p<.001). Additionally, preliminary cognitive gains emerged in Processing Speed, as measured by the Coding subtest (χ2(2)=10.47, p<.005), and in Verbal Working Memory, assessed by the Letter–Number Span (χ2(2)=10.34, p<.006), suggesting domain-specific enhancement of cognitive efficiency and working memory manipulation. Furthermore, significant reductions were noted in positive, general, and total PANSS scores, while negative symptoms remained stable. Conclusions : Peer-mediated FIE is a highly feasible and acceptable intervention for individuals with FEP. The promising preliminary signals on patient-centered functioning and specific cognitive domains strongly support the need for a large-scale randomized controlled trial with an active control group to definitively establish efficacy.
- 14 March 2025
- Published by Elsevier in Schizophrenia Research
- Vol. 278, 20-25
Toxoplasmosis infection and schizophrenia: Elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia
- 14 March 2025
- Published by Elsevier in Schizophrenia Research
- Vol. 278, 20-25
Toxoplasmosis infection and schizophrenia: Elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia
- Open Access
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 47, 1-56
A hybrid model for predicting response to risperidone after first-episode psychosis
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 47, 1-56
Open AccessA hybrid model for predicting response to risperidone after first-episode psychosis
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)
- Open Access
- 6 September 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e57031
Feuerstein Instrumental Enrichment Program for People With Schizophrenia After the First Episode of Psychosis: Protocol for an Open-Label Intervention Study
Background: Schizophrenia is a disorder associated with neurocognitive deficits that adversely affect daily functioning and impose an economic burden. Cognitive rehabilitation interventions, particularly during the early phases of illness, have been shown to improve cognition, functionality, and quality of life. The Feuerstein Instrumental Enrichment (FIE) program, based on the Mediated Learning Experience and the Structural Cognitive Modifiability theory, has been applied in various disorders, but its applicability in schizophrenia has not yet been clarified. Objective: This study aims to investigate the effects of the FIE program on the functionality of patients with first-episode schizophrenia. Methods: In total, 17 patients will be recruited for an open-label intervention consisting of twice-weekly sessions for 10 weeks. The primary outcome measure will be changes in the Goal Achievement Scale score. Maze task performance from the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery will serve as a secondary outcome measure. At the same time, changes in Positive and Negative Syndrome Scale scores and other MATRICS domains will be analyzed as exploratory outcomes. Assessments will be administered before and after the intervention, with a follow-up period of 6 months. Results: This trial was preregistered in The Brazilian Registry of Clinical Trials (RBR-4gzhy4s). By February 2024, 11 participants were enrolled in the training. Recruitment is expected to be completed by May 2024. Data analysis will be conducted between May and September 2024. The results are expected to be published in January 2025. Conclusions: This study may establish a protocol for the FIE program that uses mediation techniques for individuals in the early stages of schizophrenia. The results will add to the knowledge about strategies to promote cognitive skills and functional impairment in daily life. International Registered Report Identifier (IRRID): DERR1-10.2196/57031
- 6 September 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e57031
Open AccessFeuerstein Instrumental Enrichment Program for People With Schizophrenia After the First Episode of Psychosis: Protocol for an Open-Label Intervention Study
Background: Schizophrenia is a disorder associated with neurocognitive deficits that adversely affect daily functioning and impose an economic burden. Cognitive rehabilitation interventions, particularly during the early phases of illness, have been shown to improve cognition, functionality, and quality of life. The Feuerstein Instrumental Enrichment (FIE) program, based on the Mediated Learning Experience and the Structural Cognitive Modifiability theory, has been applied in various disorders, but its applicability in schizophrenia has not yet been clarified. Objective: This study aims to investigate the effects of the FIE program on the functionality of patients with first-episode schizophrenia. Methods: In total, 17 patients will be recruited for an open-label intervention consisting of twice-weekly sessions for 10 weeks. The primary outcome measure will be changes in the Goal Achievement Scale score. Maze task performance from the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery will serve as a secondary outcome measure. At the same time, changes in Positive and Negative Syndrome Scale scores and other MATRICS domains will be analyzed as exploratory outcomes. Assessments will be administered before and after the intervention, with a follow-up period of 6 months. Results: This trial was preregistered in The Brazilian Registry of Clinical Trials (RBR-4gzhy4s). By February 2024, 11 participants were enrolled in the training. Recruitment is expected to be completed by May 2024. Data analysis will be conducted between May and September 2024. The results are expected to be published in January 2025. Conclusions: This study may establish a protocol for the FIE program that uses mediation techniques for individuals in the early stages of schizophrenia. The results will add to the knowledge about strategies to promote cognitive skills and functional impairment in daily life. International Registered Report Identifier (IRRID): DERR1-10.2196/57031
- Open Access
- 8 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Feuerstein Instrumental Enrichment Program for People With Schizophrenia After the First Episode of Psychosis: Protocol for an Open-Label Intervention Study (Preprint)
BACKGROUND Schizophrenia is a disorder associated with neurocognitive deficits that adversely affect daily functioning and impose an economic burden. Cognitive rehabilitation interventions, particularly during the early phases of illness, have been shown to improve cognition, functionality, and quality of life. The Feuerstein Instrumental Enrichment (FIE) program, based on the Mediated Learning Experience and the Structural Cognitive Modifiability theory, has been applied in various disorders, but its applicability in schizophrenia has not yet been clarified. OBJECTIVE This study aims to investigate the effects of the FIE program on the functionality of patients with first-episode schizophrenia. METHODS In total, 17 patients will be recruited for an open-label intervention consisting of twice-weekly sessions for 10 weeks. The primary outcome measure will be changes in the Goal Achievement Scale score. Maze task performance from the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery will serve as a secondary outcome measure. At the same time, changes in Positive and Negative Syndrome Scale scores and other MATRICS domains will be analyzed as exploratory outcomes. Assessments will be administered before and after the intervention, with a follow-up period of 6 months. RESULTS This trial was preregistered in The Brazilian Registry of Clinical Trials (RBR-4gzhy4s). By February 2024, 11 participants were enrolled in the training. Recruitment is expected to be completed by May 2024. Data analysis will be conducted between May and September 2024. The results are expected to be published in January 2025. CONCLUSIONS This study may establish a protocol for the FIE program that uses mediation techniques for individuals in the early stages of schizophrenia. The results will add to the knowledge about strategies to promote cognitive skills and functional impairment in daily life. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/57031
- 8 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessFeuerstein Instrumental Enrichment Program for People With Schizophrenia After the First Episode of Psychosis: Protocol for an Open-Label Intervention Study (Preprint)
BACKGROUND Schizophrenia is a disorder associated with neurocognitive deficits that adversely affect daily functioning and impose an economic burden. Cognitive rehabilitation interventions, particularly during the early phases of illness, have been shown to improve cognition, functionality, and quality of life. The Feuerstein Instrumental Enrichment (FIE) program, based on the Mediated Learning Experience and the Structural Cognitive Modifiability theory, has been applied in various disorders, but its applicability in schizophrenia has not yet been clarified. OBJECTIVE This study aims to investigate the effects of the FIE program on the functionality of patients with first-episode schizophrenia. METHODS In total, 17 patients will be recruited for an open-label intervention consisting of twice-weekly sessions for 10 weeks. The primary outcome measure will be changes in the Goal Achievement Scale score. Maze task performance from the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery will serve as a secondary outcome measure. At the same time, changes in Positive and Negative Syndrome Scale scores and other MATRICS domains will be analyzed as exploratory outcomes. Assessments will be administered before and after the intervention, with a follow-up period of 6 months. RESULTS This trial was preregistered in The Brazilian Registry of Clinical Trials (RBR-4gzhy4s). By February 2024, 11 participants were enrolled in the training. Recruitment is expected to be completed by May 2024. Data analysis will be conducted between May and September 2024. The results are expected to be published in January 2025. CONCLUSIONS This study may establish a protocol for the FIE program that uses mediation techniques for individuals in the early stages of schizophrenia. The results will add to the knowledge about strategies to promote cognitive skills and functional impairment in daily life. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/57031
- Open Access
- 29 August 2022
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 44 (5) , 558-560
Negative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia
- 29 August 2022
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 44 (5) , 558-560
Open AccessNegative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia
- 4 January 2022
- Published by Taylor & Francis in Nordic Journal of Psychiatry
- Vol. 76 (7) , 559-564
Unraveiling the correlation among neurodevelopmental and inflammatory biomarkers in patients with chronic schizophrenia
Nuclear distribution element like-1 (Ndel1) is a cytosolic oligopeptidase, which was suggested as a potential biomarker of aberrant neurodevelopment and early stage of schizophrenia (SCZ). The invo...
- 4 January 2022
- Published by Taylor & Francis in Nordic Journal of Psychiatry
- Vol. 76 (7) , 559-564
Unraveiling the correlation among neurodevelopmental and inflammatory biomarkers in patients with chronic schizophrenia
Nuclear distribution element like-1 (Ndel1) is a cytosolic oligopeptidase, which was suggested as a potential biomarker of aberrant neurodevelopment and early stage of schizophrenia (SCZ). The invo...
- Open Access
- 1 January 2022
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 44 (6) , 731022
Clozapine prescription trends in Brazil in the last decade
Objective: Clozapine is a second-generation antipsychotic indicated for treatment-resistant schizophrenia. Studies in several countries have shown a low rate of clozapine use despite the fact that approximately 30% of schizophrenia cases are treatment-resistant. In Brazil, few studies have addressed the frequency and variety of antipsychotic use in individuals diagnosed with schizophrenia (ICD F20). The objective of this study was to measure the rates of clozapine use in this population in the last decade using Brazilian Ministry of Health data.Methods: Prescriptions made between 2010 and 2020 in all 26 states and the Federal District registered at the Outpatient Information System Database from the Brazilian Health System (SIASUS) were evaluated.Results: A total of 25,143,524 prescriptions were recorded in this period, with clozapine representing 8.86% of all antipsychotics. The most frequently prescribed antipsychotic for patients with schizophrenia was olanzapine (35.8%), followed by quetiapine (27.5%). From 2010 to 2020, the rate of clozapine prescriptions in Brazil increased from 7.2% to 10.9%.Conclusions: Despite a slight increase in prescriptions in the last decade, clozapine is still underutilized in Brazil.
- 1 January 2022
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 44 (6) , 731022
Open AccessClozapine prescription trends in Brazil in the last decade
Objective: Clozapine is a second-generation antipsychotic indicated for treatment-resistant schizophrenia. Studies in several countries have shown a low rate of clozapine use despite the fact that approximately 30% of schizophrenia cases are treatment-resistant. In Brazil, few studies have addressed the frequency and variety of antipsychotic use in individuals diagnosed with schizophrenia (ICD F20). The objective of this study was to measure the rates of clozapine use in this population in the last decade using Brazilian Ministry of Health data.Methods: Prescriptions made between 2010 and 2020 in all 26 states and the Federal District registered at the Outpatient Information System Database from the Brazilian Health System (SIASUS) were evaluated.Results: A total of 25,143,524 prescriptions were recorded in this period, with clozapine representing 8.86% of all antipsychotics. The most frequently prescribed antipsychotic for patients with schizophrenia was olanzapine (35.8%), followed by quetiapine (27.5%). From 2010 to 2020, the rate of clozapine prescriptions in Brazil increased from 7.2% to 10.9%.Conclusions: Despite a slight increase in prescriptions in the last decade, clozapine is still underutilized in Brazil.